Did not become law. It stopped in the Senate's Insurance and Real Estate Committee on February 28, 2017. The 2017 session has ended.
2017 Regular Session
Senate Bill 22
AN ACT LIMITING COST-SHARING FOR PRESCRIPTION DRUGS.
What it does
The synopsis the General Assembly published with the bill.
To limit coinsurance, copayments, deductibles and other out-of-pocket expenses imposed on insureds for prescription drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
January 9 to March 1, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action6 actions on 6 days
In the SenateJan 9 to Feb 28 · stopped50 days
Insurance and Real Estate CommitteeJan 9 to Feb 28 · stopped50 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Jan 9 – Mar 1
- Jan 9Introduced and sent to Insurance and Real Estate Committee
- Feb 2Heard in Insurance and Real Estate Committee
- Feb 28Drafted as a bill by Insurance and Real Estate Committee
- Mar 1Sent to Insurance and Real Estate Committee
All 6 actions, as published
- Jan 9REF. TO JOINT COMM. ONBoth houses
- Jan 19Reserved for Subject Matter Public HearingBoth houses
- Feb 2PUBLIC HEARINGBoth houses
- Feb 23Vote to DraftBoth houses
- Feb 28DRAFTED BY COMMITTEEBoth houses
- Mar 1REF. TO JOINT COMM. ONBoth houses